Abstract

The ability to isolate rare live cells within a heterogeneous population based solely on visual criteria remains technically challenging, due largely to limitations imposed by existing sorting technologies. Here we present a new method that permits labeling cells of interest by attaching streptavidin-coated magnetic beads to their membranes using the lasers of a confocal microscope. A simple magnet allows highly-specific isolation of the labeled cells, which then remain viable and proliferate normally. As proof of principle, we tagged, isolated, and expanded individual cells based on three biologically-relevant visual characteristics: i) presence of multiple nuclei, ii) accumulation of lipid vesicles, and iii) ability to resolve ionizing radiation-induced DNA damage foci. Our method constitutes a rapid, efficient, and cost-effective approach for isolation and subsequent characterization of rare cells based on observable traits such as movement, shape, or location, which in turn can generate novel mechanistic insights into important biological processes.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files

Article and author information

Author details

  1. Loïc Binan

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  2. François Bélanger

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  3. Maxime Uriarte

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  4. Jean François Lemay

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3540-1627
  5. Jean Christophe Pelletier De Koninck

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  6. Joannie Roy

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  7. El Bachir Affar

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  8. Elliot Drobetsky

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  9. Hugo Wurtele

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  10. Santiago Costantino

    Research Center, Maisonneuve-Rosemont Hospital, Montreal, Canada
    For correspondence
    santiago.costantino@umontreal.ca
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2454-2635

Funding

Canadian Institutes of Health Research

  • El Bachir Affar
  • Elliot Drobetsky
  • Hugo Wurtele

Natural Sciences and Engineering Research Council of Canada

  • El Bachir Affar
  • Elliot Drobetsky
  • Hugo Wurtele
  • Santiago Costantino

Genome Canada

  • Santiago Costantino

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Maddy Parsons, King's College London, United Kingdom

Version history

  1. Received: January 16, 2019
  2. Accepted: April 9, 2019
  3. Accepted Manuscript published: April 10, 2019 (version 1)
  4. Version of Record published: May 3, 2019 (version 2)

Copyright

© 2019, Binan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,159
    views
  • 321
    downloads
  • 9
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Loïc Binan
  2. François Bélanger
  3. Maxime Uriarte
  4. Jean François Lemay
  5. Jean Christophe Pelletier De Koninck
  6. Joannie Roy
  7. El Bachir Affar
  8. Elliot Drobetsky
  9. Hugo Wurtele
  10. Santiago Costantino
(2019)
Opto-magnetic capture of individual cells based on visual phenotypes
eLife 8:e45239.
https://doi.org/10.7554/eLife.45239

Share this article

https://doi.org/10.7554/eLife.45239

Further reading

    1. Cancer Biology
    Chenxi Gao, Huaibin Ge ... Jing Hu
    Research Article

    BRAFV600E mutation is a driver mutation in the serrated pathway to colorectal cancers. BRAFV600E drives tumorigenesis through constitutive downstream extracellular signal-regulated kinase (ERK) activation, but high-intensity ERK activation can also trigger tumor suppression. Whether and how oncogenic ERK signaling can be intrinsically adjusted to a ‘just-right’ level optimal for tumorigenesis remains undetermined. In this study, we found that FAK (Focal adhesion kinase) expression was reduced in BRAFV600E-mutant adenomas/polyps in mice and patients. In Vil1-Cre;BRAFLSL-V600E/+;Ptk2fl/fl mice, Fak deletion maximized BRAFV600E’s oncogenic activity and increased cecal tumor incidence to 100%. Mechanistically, our results showed that Fak loss, without jeopardizing BRAFV600E-induced ERK pathway transcriptional output, reduced EGFR (epidermal growth factor receptor)-dependent ERK phosphorylation. Reduction in ERK phosphorylation increased the level of Lgr4, promoting intestinal stemness and cecal tumor formation. Our findings show that a ‘just-right’ ERK signaling optimal for BRAFV600E-induced cecal tumor formation can be achieved via Fak loss-mediated downregulation of ERK phosphorylation.

    1. Cancer Biology
    2. Computational and Systems Biology
    Marie Breeur, George Stepaniants ... Vivian Viallon
    Research Article

    Untargeted metabolomic profiling through liquid chromatography-mass spectrometry (LC-MS) measures a vast array of metabolites within biospecimens, advancing drug development, disease diagnosis, and risk prediction. However, the low throughput of LC-MS poses a major challenge for biomarker discovery, annotation, and experimental comparison, necessitating the merging of multiple datasets. Current data pooling methods encounter practical limitations due to their vulnerability to data variations and hyperparameter dependence. Here, we introduce GromovMatcher, a flexible and user-friendly algorithm that automatically combines LC-MS datasets using optimal transport. By capitalizing on feature intensity correlation structures, GromovMatcher delivers superior alignment accuracy and robustness compared to existing approaches. This algorithm scales to thousands of features requiring minimal hyperparameter tuning. Manually curated datasets for validating alignment algorithms are limited in the field of untargeted metabolomics, and hence we develop a dataset split procedure to generate pairs of validation datasets to test the alignments produced by GromovMatcher and other methods. Applying our method to experimental patient studies of liver and pancreatic cancer, we discover shared metabolic features related to patient alcohol intake, demonstrating how GromovMatcher facilitates the search for biomarkers associated with lifestyle risk factors linked to several cancer types.